Neuronetics, Inc. Common Stock
Here’s whether Neuronetics, Inc. Common Stock (STIM) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Caution.
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.06% over 10 days). Concerns: trading below the 200-day MA (long-term downtrend); RSI 82 — overbought, elevated pullback risk; weak 1-year return of -54.7%. Currently 58.4% off its 52-week high. Score: -2/7.
STIM is trading below its 200-day MA ($2.27) — a key warning sign the longer-term trend is under pressure. With an RSI of 81.8, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -54.7% compares to +22.9% for SPY (trailed the market by 77.6%). The current 58.4% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.